Infection Control Today® Editorial Staff

Articles by Infection Control Today® Editorial Staff

Pfizer logo in New York, NY  (Adobe Stock 432350550 by Kathy images)

Pfizer Inc, has released promising top-line data for its Abrysvo vaccine, demonstrating high efficacy against respiratory syncytial virus (RSV) in adults aged 60 and older. These findings from the Phase 3 clinical trial hold significant implications for infection control personnel working to combat RSV infections, especially in vulnerable populations.

Continuous glucose monitors used by a patient with diabetics  (Adobe Stock 494211341 by Goffkein)

Tina Platania discusses the significance of continuous glucose monitors (CGM) in diabetes care, highlighting CCS's individualized approach based on medical necessity. From carefully considering patient needs to collaborating with providers and payers, CCS ensures a highly personalized treatment plan, reflecting their commitment to improving overall health.